Perspectives on the clinical aspects of the meeting from Professor Jorge Cortes
MD Anderson Cancer Center
University of Texas, Houston (USA)

• Update on new studies including TIGER and SPIRIT II 
• Long-term outcomes from clinical studies on treatment-discontinuation
• Various aspects on treatment-free-remission such as predictors of success, biomarkers, gene analysis, use of digital PCR, pregnancy
• New modalities and tools of monitoring patients 
• Biology of CML and the role of microenvironment and molecular abnormalities

 {rscomments off}